Safety, Tolerability, and Pharmacokinetics of Oral NX-13 in Active Ulcerative Colitis

Clinical trial NCT04862741 · COMPLETED

Trial details

NCT number: NCT04862741
Sponsor: Landos Biopharma Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Ulcerative Colitis

Start date: 2021-05-05
Primary completion: 2022-06-17
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.